Rights and permissions
About this article
Cite this article
PEP should be better targeted in France to enhance cost effectiveness. Pharmacoecon. Outcomes News 474, 6 (2005). https://doi.org/10.2165/00151234-200504740-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504740-00010